Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bone

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S8756-3282(00)00355-0PMID 11033441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum.

  2000cited by this paper
• Effects of age, estrogen depletion, and parathyroid hormone treatment on vertebral cancellous wall width in female rats.

  1999cited by this paper
• Osteoporosis: Current approaches and future prospects in diagnosis, pathogenesis, and management

  1999cited by this paper
• Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: implications for design of signal-specific PTH ligands.

  1999cited by this paper
• Cell-specific signaling and structure-activity relations of parathyroid hormone analogs in mouse kidney cells.

  1999cited by this paper
• Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

  1999cited by this paper
• Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats.

  1999cited by this paper
• Recombinant Human Insulin-Like Growth Factor-Binding Protein-5 Stimulates Bone Formation Parameters in Vitro and in Vivo1.

  1999cited by this paper
• Interactions of PTH and PTHrP with the PTH/PTHrP Receptor and with Downstream Signaling Pathways: Exceptions That Provide the Rules

  1999cited by this paper
• Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo.

  1999cited by this paper
• Cell-Specific Signaling and Structure-Activity Relations of Parathyroid Hormone Analogs in Mouse Kidney Cells* * This work was supported by NIH Grant R01-DK-54171 and an American Society of Nephrology Career Enhancement Award.

  1999cited by this paper
• Dual Signaling and Ligand Selectivity of the Human PTH/PTHrP Receptor

  1999cited by this paper
• The diagnosis and treatment of osteoporosis: future prospects.

  1999cited by this paper
• Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans.

  1999cited by this paper
• Increased osteoblastic c-fos expression by parathyroid hormone requires protein kinase A phosphorylation of the cyclic adenosine 3',5'-monophosphate response element-binding protein at serine 133.

  1999cited by this paper
• Type-1 Parathyroid Hormone (PTH)/PTH-Related Peptide (PTHrP) Receptors Activate Phospholipase C in Response to Carboxyl-Truncated Analogs of PTH(1-34)* * This work was supported by National Institutes of Health Grant DK-11794.

  1998cited by this paper
• Skeletal Response to Dietary Zinc in Adult Female Mice

  1998cited by this paper
• Comparison of the Abilities of Human Parathyroid Hormone (hPTH)-(1-34) and [Leu27]-cyclo(Glu22-Lys26)-hPTH-(1-31)NH2 to Stimulate Femoral Trabecular Bone Growth in Ovariectomized Rats

  1998cited by this paper
• Functional analysis of the PTH/PTHrP network of ligands and receptors.

  1998cited by this paper
• Comparison of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia.

  1998cited by this paper
• Accretion of Bone Mass and Strength with Parathyroid Hormone Prior to the Onset of Estrogen Deficiency Can Provide Temporary Beneficial Effects in Skeletally Mature Rats

  1998cited by this paper
• Type-1 parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptors activate phospholipase C in response to carboxyl-truncated analogs of PTH(1-34).

  1998cited by this paper
• The Mitogenic Effect of Parathyroid Hormone Is Associated with E2F‐Dependent Activation of Cyclin‐Dependent Kinase 1 (cdc2) in Osteoblast Precursors

  1997cited by this paper
• The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.

  1997cited by this paper
• No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model.

  1997cited by this paper
• An Intact N Terminus Is Required for the Anabolic Action of Parathyroid Hormone on Adult Female Rats

  1997cited by this paper
• Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities.

  1997cited by this paper
• Effects of parathyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell proliferation.

  1996cited by this paper
• Parathyroid hormone stimulation of calcium transport is mediated by dual signaling mechanisms involving protein kinase A and protein kinase C.

  1996cited by this paper
• Analysis of signaling pathways used by parathyroid hormone to activate the c‐fos gene in human SaOS2 osteoblast‐like cells

  1996cited by this paper
• Genetic variability in adult bone density among inbred strains of mice.

  1996cited by this paper
• Bone‐selective analogs of human PTH(1–34) increase bone formation in an ovariectomized rat model

  1996cited by this paper
• Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo.

  1996cited by this paper
• Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats.

  1995cited by this paper
• Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1–38) in right hindlimb immobilized rats

  1995cited by this paper
• Anabolic effect of parathyroid hormone is not modified by supplementation with insulinlike growth factor I (IGF-I) or growth hormone in aged female rats fed an energy-restricted or ad libitum diet.

  1995cited by this paper
• A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats

  1995cited by this paper
• The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.

  1995cited by this paper
• Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.

  1995cited by this paper
• Effects of on/off anabolic hPTH and remodeling inhibitors on metaphyseal bone of immobilized rat femurs. Tomographical (pQCT) description and correlation with histomorphometric changes in tibial cancellous bone.

  1995cited by this paper
• Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.

  1995cited by this paper
• Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway.

  1995cited by this paper
• Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids.

  1994cited by this paper
• The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats.

  1994cited by this paper
• Further definition of the protein kinase C activation domain of the parathyroid hormone

  1994cited by this paper
• Human parathyroid hormone(1-34) increases bone formation and strength of cortical bone in aged rats.

  1994cited by this paper
• Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase

  1994cited by this paper
• New reagent for colorimetric assay of calcium in serum.

  1993cited by this paper
• Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum.

  1993cited by this paper
• Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol.

  1993cited by this paper
• Structure-function relationship of parathyroid hormone: activation of phospholipase-C, protein kinase-A and -C in osteosarcoma cells.

  1992cited by this paper
• Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone.

  1989cited by this paper
• Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture.

  1989cited by this paper
• Structure‐activity relationships of parathyroid hormone analogs in the opossum kidney cell line

  1989cited by this paper
• Printed in U.S.A. Copyright © 1997 by The Endocrine Society Biosynthetic Human Parathyroid Hormone (1–34) Effects on Bone Quality in Aged Ovariectomized Rats

  year unknowncited by this paper

• Flavors of GPCR signaling bias.

  2024cites this paper
• First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product

  2024cites this paper
• Sustainable Bioactive Composite of Glehnia littoralis Extracts for Osteoblast Differentiation and Bone Formation

  2023cites this paper
• PTH Treatment Increases Cortical Bone Mass More in Response to Compression than Tension in Mice

  2022cites this paper
• Contrasting effects of Ksr2, an obesity gene, on trabecular bone volume and bone marrow adiposity

  2022cites this paper
• Enhanced oral absorption of teriparatide with therapeutic potential for management of osteoporosis.

  2022cites this paper
• Parathyroid Glands in CKD: Anatomy, Histology, Physiology and Molecular Biology in CKD

  2020cites this paper
• Effect of Different Doses of Synthetic Parathyroid Hormone (1-34) on Bone around Implants: a Preclinical Rat Model.

  2019cites this paper
• A Randomized Double‐Blind Placebo‐Controlled First‐In‐Human Phase 1 Trial of TransCon PTH in Healthy Adults

  2019influential citation
• Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide

  2018cites this paper
• Parathyroid Hormone (PTH) Increases Skeletal Tumour Growth and Alters Tumour Distribution in an In Vivo Model of Breast Cancer

  2018cites this paper
• Parathyroid hormone gene‐activated matrix with DFDBA/collagen composite matrix enhances bone regeneration in rat calvarial bone defects

  2018cites this paper
• Translating in vitro ligand bias into in vivo efficacy.

  2018cites this paper
• CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone

  2017cites this paper
• One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption

  2017cites this paper
• Running Title: Climate change in GPCR drug discovery?

  2017cites this paper
• Synthesis of novel 5,6-dehydrokawain analogs as osteogenic inducers and their action mechanisms.

  2017cites this paper
• The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling

  2017cites this paper
• 5,6-Dehydrokawain from Alpinia zerumbet promotes osteoblastic MC3T3-E1 cell differentiation

  2016cites this paper
• Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.

  2016cites this paper
• Synthetic Parathyroid Hormone May Augment Bone Volume in Autogenous Grafts: A Study in Rats.

  2016cites this paper
• Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism

  2015cites this paper
• Influência de diferentes doses de PTH sintético (1-34) sobre a reparação de enxertos ósseos autógenos. Estudo em ratos

  2015cites this paper
• Influência de diferentes doses de PTH sintético (1-34) sobre a reparação de enxertos ósseos autógenos. Estudo em ratos

  2015cites this paper
• 9-Demethoxy-medicarpin promotes peak bone mass achievement and has bone conserving effect in ovariectomized mice: Positively regulates osteoblast functions and suppresses osteoclastogenesis.

  2015cites this paper
• size and bone formation in mice erythroid-derived 2-like 1 in osteoblasts reduces bone Targeted disruption of nuclear factor

  2015cites this paper
• Tissue engineered bone using select growth factors: A comprehensive review of animal studies and clinical translation studies in man.

  2014influential citation
• Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.

  2014cites this paper
• Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.

  2013cites this paper
• Phenotypic Characterization of Peripheral Osteoclast Precursors their Lineage Relation to Macrophages and Dendritic Cells and their Population Dynamics Influenced by Parathyroid Hormone and Inflammatory Signals.

  2013cites this paper
• β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo.

  2013cites this paper
• Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.

  2013cites this paper
• Arrestin pathways as drug targets.

  2013cites this paper
• Emergent biological properties of arrestin pathway-selective biased agonism

  2013influential citation
• Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans

  2012cites this paper
• Parathyroid Hormone in the Treatment of Osteoporosis

  2012cites this paper
• Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation

  2012cites this paper
• The influence of parathyroid hormone treatment on implant fixation.

  2011cites this paper
• A Prunus mume Extract Stimulated the Proliferation and Differentiation of Osteoblastic MC3T3-E1 Cells

  2011cites this paper
• Refining efficacy: allosterism and bias in G protein-coupled receptor signaling.

  2011cites this paper
• Refining efficacy: exploiting functional selectivity for drug discovery.

  2011influential citation
• Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow

  2011cites this paper
• A new norlupane triterpene from the leaves of Acanthopanax koreanum increases the differentiation of osteoblastic MC3T3-e1 cells

  2010cites this paper
• Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.

  2010cites this paper
• Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH.

  2010cites this paper
• Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling

  2010influential citation
• Short-term intermittent PTH 1-34 administration enhances bone formation in SCID/Beige mice.

  2010cites this paper
• Parathyroid hormone synergizes with non‐cyclic AMP pathways to activate the cyclic AMP response element

  2009cites this paper
• New neolignan component from Camellia amplexicaulis and effects on osteoblast differentiation.

  2009cites this paper
• Glucocorticoid-Induced Osteoporosis in Growing Mice Is Not Prevented by Simultaneous Intermittent PTH Treatment

  2009cites this paper
• A new monoterpene glycoside from the roots ofPaeonia lacti- flora increases the differentiation of osteoblastic MC3T3-E1 cells

  2007cites this paper
• Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.

  2007cites this paper
• Materials in particulate form for tissue engineering. 2. Applications in bone

  2007cites this paper
• Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.

  2007cites this paper
• Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.

  2007cites this paper
• Degradation of teriparatide by gastro-intestinal proteolytic enzymes

  2006cites this paper
• Identification of a PTH regulated gene selectively induced in vivo during PTH‐mediated bone formation

  2006cites this paper
• In Vitro & In Vivo Effect of Parathyroid Hormone Analogue (1-14) Containing α-amino-iso-butyric Acid Residue (Aib)1,3

  2006cites this paper
• Strategies to improve plasma half life time of peptide and protein drugs

  2006cites this paper
• Disruption of Four-and-a-Half LIM 2 Decreases Bone Mineral Content and Bone Mineral Density in Femur and Tibia Bones of Female Mice

  2006cites this paper
• Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.

  2006cites this paper
• The parathyroid polyhormone hypothesis revisited.

  2006cites this paper
• Bone turnover mediates preferential localization of prostate cancer in the skeleton.

  2005cites this paper
• The licorice root derived isoflavan glabridin increases the function of osteoblastic MC3T3-E1 cells.

  2005cites this paper
• Verbesserung des Integrationsverhaltens von PMMA-Zement durch osteogenetische Faktoren bei Osteoporose

  2005cites this paper
• Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation

  2005cites this paper
• Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.

  2005cites this paper
• Delivery of parathyroid hormone for the treatment of osteoporosis

  2005cites this paper
• In vivo Antiosteoporotic Activity of a Fraction of Dioscorea spongiosa and its Constituent, 22-O-Methylprotodioscin

  2004cites this paper
• β‐Arrestin2 Regulates the Differential Response of Cortical and Trabecular Bone to Intermittent PTH in Female Mice

  2004cites this paper
• In vitro and in vivo activities of C-terminally truncated PTH peptides reveal a disconnect between cAMP signaling and functional activity.

  2004cites this paper
• Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis.

  2004cites this paper
• In vivo antiosteoporotic activity of a fraction of Dioscorea spongiosa and its constituent, 22-O-methylprotodioscin.

  2004cites this paper
• Treatment with Parathyroid Hormone hPTH(1-34), hPTH(1-31), and Monocyclic hPTH(1-31) Enhances Fracture Strength and Callus Amount After Withdrawal Fracture Strength and Callus Mechanical Quality Continue to Increase

  2004cites this paper
• Response of induced bone defects in horses to collagen matrix containing the human parathyroid hormone gene.

  2004cites this paper
• Antiosteoporotic activity of the water extract of Dioscorea spongiosa.

  2004cites this paper
• Periosteum: biology, regulation, and response to osteoporosis therapies.

  2004cites this paper
• Parathyroid hormone induces E4bp4 messenger ribonucleic acid expression primarily through cyclic adenosine 3',5'-monophosphate signaling in osteoblasts.

  2004cites this paper
• Precision and accuracy of peripheral quantitative computed tomography (pQCT) in the mouse skeleton compared with histology and microcomputed tomography (microCT).

  2003cites this paper
• Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation.

  2003cites this paper
• Osteocrin, a Novel Bone-specific Secreted Protein That Modulates the Osteoblast Phenotype*

  2003cites this paper
• Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice.

  2003cites this paper
• Accuracy of peripheral quantitative computed tomography (pQCT) for assessing area and density of mouse cortical bone.

  2003cites this paper
• Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone*

  2003cites this paper
• Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

  2003cites this paper
• Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice.

  2003cites this paper
• Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone

  2003cites this paper
• Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice.

  2003cites this paper
• Precision and Accuracy of Peripheral Quantitative Computed Tomography (pQCT) in the Mouse Skeleton Compared With Histology and Microcomputed Tomography (μCT)

  2003cites this paper
• Actions of Parathyroid Hormone

  2002cites this paper
• Developments in parathyroid hormone and related peptides as bone-formation agents.

  2002cites this paper
• Bone growth stimulators. New tools for treating bone loss and mending fractures.

  2002cites this paper
• Anabolic Action of Parathyroid Hormone Is Skeletal Site Specific at the Tissue and Cellular Levels in Mice

  2002cites this paper
• Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos.

  2002cites this paper
• Universidade Estadual de Campinas

  2002cites this paper
• Effects of Daily Treatment with Parathyroid Hormone on Bone Microarchitecture and Turnover in Patients with Osteoporosis: A Paired Biopsy Study *

  2001cites this paper
• Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.

  2001cites this paper
• Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis.

  2001cites this paper
• The effect of monocyclic and bicyclic analogs of human parathyroid hormone (hPTH)-(1-31)NH2 on bone formation and mechanical strength in ovariectomized rats

  2001cites this paper
• Stimulation of Protein Kinase C Activity in Cells Expressing Human Parathyroid Hormone Receptors by C‐ and N‐Terminally Truncated Fragments of Parathyroid Hormone 1–34

  2001influential citation